EGX: MCRO Revenue

Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 163.96M EGP in the quarter ending September 30, 2024, a decrease of -35.01%. This brings the company's revenue in the last twelve months to 255.68M, down -67.99% year-over-year. In the year 2023, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 526.01M, down -27.91%.

Revenue (ttm)

255.68M

Revenue Growth

-67.99%

P/S Ratio

5.62

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	526.01M	-203.61M	-27.91%
Dec 31, 2022	729.61M	135.35M	22.78%
Dec 31, 2021	594.26M	163.76M	38.04%
Dec 31, 2020	430.50M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition